Repligen Corporation (RGEN) Covered Calls
Repligen Corporation develops and manufactures advanced bioprocessing technologies for the global biopharmaceutical industry. The enterprise engineers specialized filtration systems, chromatography purification columns, fluid management assemblies, and process analytics tools. By provisioning high-efficiency manufacturing components to biological drug developers, the organization anchors critical clinical pipeline delivery loops.
You can sell covered calls on Repligen Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RGEN (prices last updated Thu 12:25 PM ET):
| Repligen Corporation (RGEN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 147.11 | +8.71 | 146.92 | 147.30 | 735K | 154 | 7.8 |
| Covered Calls For Repligen Corporation (RGEN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Jul 17 | 145 | 8.30 | 139.00 | 4.3% | 68.2% | |
| Aug 21 | 145 | 13.40 | 133.90 | 8.3% | 52.2% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Repligen Corporation operates a scaled bioprocessing technology development, fluid mechanics filtration engineering, and industrial protein chromatography manufacturing framework within the healthcare sector, specialized in clinical drug production loops. The corporation directs multi-state automated cleanrooms, advanced hollow-fiber membrane weaving lines, single-use fluid distribution hubs, and real-time inline concentration sensor facilities. By embedding its high-purity components directly into commercial biological factories, the company functions as an essential biopharmaceutical processing utility.
The enterprise yields its primary revenue configurations through recurring consumables product sales and equipment rentals across four foundational technology pillars: Filtration systems, Chromatography purification setups, Process Analytics hardware, and foundational Fluid Management assemblies.
Competitive Landscape
The international bioprocessing equipment marketplace, pharmaceutical filtration grid, and life sciences material arena are deeply research-heavy, strictly regulated, and highly responsive to global clinical pipeline expansions, biomanufacturing factory utilization layers, and international biotech funding cycles. Repligen competes based on its proprietary hollow-fiber membrane patents, single-use system optimization metrics, software analytics integration speeds, and strict cleanroom quality assurance protocols. Key industry peers with highly optionable equities trading on major exchanges include:
- Agilent Technologies, Inc.: Coordinates a massive international analytical instruments, life sciences software, and laboratory workflow consumables portfolio with deep public option chain liquidity.
- West Pharmaceutical Services, Inc.: Manufactures premium containment and delivery systems for injectable drugs and biologic therapies backed by an exceptionally active public options framework.
- Mettler-Toledo International Inc.: Directs substantial high-precision weighing systems and analytical laboratory instrumentation networks across major liquid option trading grids.
- Waters Corporation: Coordinates extensive analytical workflow platforms, high-performance liquid chromatography arrays, and mass spectrometry tools via an active options chain.
Strategic Outlook and Innovation
Repligen Corporation is focused on aggressively scaling its higher-margin single-use filtration and real-time analytics divisions, actively capitalizing on global market expansion trends across commercial monoclonal antibody, mRNA vaccine, and cell therapy manufacturing portfolios. The company's long-term business layout prioritizes structural portfolio optimization, utilizing highly targeted engineering acquisitions to onboard complementary fluid mechanics patents while maintaining a clean, debt-free capital profile to protect corporate equity from macro credit contractions. This structural flexibility supports uninterrupted internal research and development pipelines.
Future engineering priorities center on deploying advanced automated laser-welding robotics and integrated inline sensory arrays directly onto its single-use fluid assembly manufacturing floors, systematically eliminating macro-contamination risk vectors before systems are shipped to pharmaceutical cleanrooms. The company continues to implement cloud-native real-time predictive data logging features across its analytics hardware lines to allow manufacturing technicians to monitor batch concentration changes seamlessly. These system updates are engineered to protect cash flow runways.
| Top 10 Open Interest For Jul 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | WULF covered calls | 1. | TE covered calls | |
| 2. | SLV covered calls | 7. | NFLX covered calls | 2. | WEN covered calls | |
| 3. | TLT covered calls | 8. | BTDR covered calls | 3. | FCEL covered calls | |
| 4. | EWZ covered calls | 9. | KWEB covered calls | 4. | BB covered calls | |
| 5. | SPY covered calls | 10. | AAPL covered calls | 5. | FRMI covered calls | |
Want more examples? RGC Covered Calls | RGLD Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
